Ana Luisa Silva

Ana Luisa Silva

Universidade de Lisboa - Lisboa / Portugal
Engineering & Technology / Nanoscience and Nanotechnology
AD Scientific Index ID: 4369009
University of Lisbon
person_outline Ana Luisa Silva's MOST POPULAR ARTICLES
1-) CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responsesRA Rosalia, LJ Cruz, S van Duikeren, AT Tromp, AL Silva, W Jiskoot, ...Biomaterials 40, 88-97, 20152542015
2-) Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activationMCJ Rosalia RA, Quakkelaar ED, Redeker A, Khan SEuropean Journal of Immunology, 20132022013
3-) PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicityAL Silva, PC Soema, B Slütter, F Ossendorp, W JiskootHuman vaccines & immunotherapeutics 12 (4), 1056-1069, 20161772016
4-) Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activationAL Silva, RA Rosalia, E Varypataki, S Sibuea, F Ossendorp, W JiskootVaccine 33 (7), 847-854, 20151462015
5-) Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: Low-burst release is crucial for efficient CD8+ T cell activationAL Silva, RA Rosalia, A Sazak, MG Carstens, F Ossendorp, J Oostendorp, ...European Journal of Pharmaceutics and Biopharmaceutics 83 (3), 338-345, 20131332013